|Videos|May 30, 2023

CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment

Author(s)Medidata

KEY LEARNING OBJECTIVES

  • Audience will have an understanding how Medidata can have an impact with Clinical Trial pharma and bio tech firms that are working in this therapeutic area
  • What are the challenges that CAR-T developers face and how can data help address those challenges
  • How is Medidata AI “data” different from other data providers

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content